Kuros Biosciences Completes Enrollment of Randomized Stage&#

Kuros Biosciences AG / Key word(s): Miscellaneous Kuros Biosciences Completes Enrollment of Randomized Stage of Phase 2 Trial for Fibrin-PTH 23.11.2022 / 07:00 CET/CEST First investigational trial of drug-biologic bone graft for spinal fusion No drug-related Serious Adverse Events (SAEs) reporte...

Related Keywords

Zurich , Züsz , Switzerland , United States , Netherlands , Swiss , Kuros Biosciences , Michael Grau , Drug Administration , News Service , Swiss Exchange , Biosciences Completes Enrollment , Randomized Stage , Serious Adverse Events , Investigational New Drug , Chief Executive Officer , Sci Advisors , Lumbar Interbody Fusion , Kuros , Iosciences , Ompletes , Enrollment , Randomized , Stage Of , Hase , Trial , Ibrin Pth , Et Cest , First , O , Serious , Madverse , Events ,